Latest News

  • ‘Pooling’ Test Samples and Dipstick Technology, Persistent Symptoms During Pregnancy, At Home Finger Prick Test: COVID-19 Updates

    Diagnostics World News | New ‘dipstick’ technology developed at the University of Queensland can quickly extract genetic material in as little as 30 seconds; CalTech researchers develop new sensor named SARS-CoV-2 RapidPlex; and dried blood spot samples are as accurate in detecting SARS-CoV-2 antibodies as venous blood samples study finds. Plus: NIH announces new RADx initiative contracts totaling $98.35 million; University of Minnesota AI evaluates chest X-rays to diagnose COVID-19; Boston launches TestBoston to track previous infection; and more.

    Oct 9, 2020
  • 3D Swabs, Saliva Sampling, Anosmia, Delirium: COVID-19 Updates

    Diagnostics World News | Dialysis patients could help surveillance efforts, risk-raising genetic mutations, comparing return-to-work protocols, counting breaths, 3D nasal swabs and saliva sampling make the mark, cool tool for rapid antibody detection, resuming anticancer therapy, an Android app to analyze the SARS-CoV-2 genome, loss of smell, delirium in the elderly, AI+CT for diagnosing COVID-19. Plus, detecting fever from a distance, a COVID-19 biorepository expands to include convalescent plasma, more funding to improve testing for underserved populations, a smartwatch for asymptomatic individuals, and more of the latest news from around the U.S. and Europe.

    Oct 2, 2020
  • The Future of Wearables Could Be Electronic Tattoos

    Diagnostics World News | New research offers a glimpse into the future of wearables, which may use everyday tools like pens, pencils, and paper to draw monitoring devices directly onto skin.

    Sep 30, 2020
  • The Lowdown On Companion Diagnostics

    Diagnostics World News | Companion diagnostics (CDx) in precision medicine can be advanced by using routinely collected real-world data (RWD) to support regulatory submissions, FDA representatives explained.

    Sep 28, 2020
  • CRISPR Diagnostics, Mass General’s Recommendations On Testing, Robot Swabber: COVID-19 Updates

    Diagnostics World News | New CRISPR COVID-19 diagnostics from the University of Connecticut and MIT/Broad, Mass General compares testing strategies and recommends wide screening, and King’s College London doctors recommend CT scans to flag COVID-19 lung issues. Plus, Singapore invents the SwabBot—a robot swabber, DetectaChem releases portable test pouches, and Pacific Northwest National Lab validates diagnostic kits.

    Sep 25, 2020
  • Advice On Commercializing Point-Of-Care Technologies

    Diagnostics World News | A better diagnostic platform enabling near-patient testing of disease biomarkers, including the presence of antibodies indicative of previous SARS-CoV-2 infection, as well as advice on how to build and fund new point-of-care (POC) platforms, were among the topics covered during last month’s virtual Next Generation Dx Summit.

    Sep 24, 2020
  • The Promise And Perils Of Home-Use Tests

    Diagnostics World News | The FDA’s regulatory process for home-use tests, including Emergency Use Authorizations (EUAs), and concerns surrounding in-home sample collection, were the focus of a series of talks at the recent Next Generation Dx Summit. While increasing access to testing, particularly during a pandemic, home-use tests come with significant challenges that include fairly weighing the risks and benefits, points out conference speaker Elliot Cowan, principal and founder of Partners in Diagnostics.

    Sep 21, 2020
  • CMR Imaging Of Athletes, Role For Thermography, Watch Pulse Oximeter Levels: COVID-19 Updates

    Diagnostics World News | Differing nasal expressions in blacks, a risk stratification tool for athletes, a new antibody test for identifying plasma donors, warning for patients with sleep apnea, the utility of infrared thermographs, lower pulse oximetry levels and fever lead reasons for rehospitalizations, and a Lab-in-Cartridge device rolling out across the U.K. Plus, a dual-purpose nonprofit, computing how to allocate test kits, seven digital health solutions receive NIH funding, and efforts underway to standardize SARS-CoV-2 assays.

    Sep 18, 2020
  • Diagnostic Stewardship: Better Care At A Lower Cost

    Diagnostics World News | Diagnostic stewardship was a trending topic at the recent Next Generation Dx Summit, and the highlights included presentations by Christopher Doern, director of clinical microbiology at Virginia Commonwealth University (VCU) Health System and the Medical College of Virginia, and Matt Binnicker, director of clinical virology and vice chair of practice in the department of laboratory medicine and pathology at the Mayo Clinic. Both offered practical advice and tips for improving patient care under real-world budget and workforce constraints.

    Sep 16, 2020
  • Follow the Money: Cancer Blood Tests, Regulatory Information Management

    Diagnostics World News | Big money for Freenome’s colorectal cancer blood test, investments in the Regulatory Information Management market, and more.

    Sep 14, 2020
  • Antibody Test-On-A-Chip, New Mortality Score, Chest X-Rays In Diagnostics: COVID-19 Updates

    Diagnostics World News| Harvard researchers have optimized new SARS-CoV-2 diagnostic, antibody test-on-a-chip uses gold nanospikes for virus detection, 4C Mortality Score predicts disease outcome, and LSU radiologists argue for chest x-rays in COVID-19 diagnostics. Plus, scaled up testing, AI-powered reopening, more testing receives EUAs.

    Sep 11, 2020
  • Post-Pandemic, Payers May Be Reining In Telemedicine

    Diagnostics World News | Telemedicine is probably not appreciably lowering the overall cost of patient care, according to Maria Turner, managing director at global management consulting firm AArete. Post-pandemic, Turner expects the telemedicine landscape will look a lot different than it does today.

    Sep 10, 2020
  • Moving From Why To How With Personalized Medicine Technologies

    Diagnostics WorldOncologists often make decisions about diagnostic tests with very little information to go on, and the dearth of high-quality evidence has made it difficult for both doctors and institutions to advance personalized medicine without a roadmap for overcoming the challenges, which the Personalized Medicine Coalition (PMC) has been developing. At the recent Next Generation Dx Summit, speakers explored how oncologists choose and evaluate such tests.

    Sep 8, 2020
  • Speed To Answers, Viral Spreaders, Symptom Data Challenge: COVID-19 Updates

    Diagnostics World News | A CRISPR-based assay and smartphone-based molecular test, the role of children in viral spread, using pressure to concentrate samples, a patient scoring system, timetable on retesting, two tests are better than one, and deep dives on older patients. Plus, the COVID-19 Symptom Data Challenge and nine more companies get NIH grants to scale up COVID-19 testing.

    Sep 4, 2020
  • Rules of the Regulatory Road For Companion Diagnostics

    Diagnostics World News | The regulatory framework around drug and diagnostic co-development, and how to overcome the inevitable hurdles, was the subject of multiple presentations at the 12th Annual Next Generation Dx Summit held virtually last week.

    Sep 1, 2020
  • Racial Impacts, Inflammation Markers, Two New Saliva Tests: COVID-19 Updates

    Diagnostics World News | Census data shows COVID-19 follows HIV patterns of racial segregation, how virtual imaging studies can help, inflammation markers that predict severe disease, and models of early transmission. Plus, two EUAs for saliva tests and back-to-work testing.

    Aug 28, 2020
  • Lessons Learned From A Pandemic: Next Generation Dx Summit Day Two

    Diagnostics World News | Day two of the Next Generation Dx Summit was highlighted by a spirited panel discussion on the lessons learned during the pandemic, as well as some practical guidance on the development of next-generation diagnostics.

    Aug 26, 2020
  • New CMS Rules For Nursing Homes, Testing, Reporting COVID-19

    Diagnostics World News | Yesterday, the Centers for Medicare & Medicaid Services (CMS) announced regulatory changes that require nursing homes to test staff and offer testing to residents for COVID-19. Laboratories and nursing homes using point-of-care testing devices will be required to report diagnostic test results as required by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). The new rules also require hospitals to provide COVID-19 cases and related data to the U.S. Department of Health and Human Services (HHS).

    Aug 26, 2020
  • Updates on CDx, Feedback from FDA: Next Generation Dx Summit Day One

    Diagnostics World News | At day one of the Next Generation Dx Summit, MD Anderson Cancer Center highlighted “unprecedented opportunities” for blood-based biomarkers in cancer detection, Merck weighed in on the regulatory environment for companion diagnostics, FDA gave an update on selected precision oncology initiatives of the agency, and more.

    Aug 25, 2020
  • Adaptive Biotechnologies, Strata Oncology, And More: News From August 2020

    Diagnostics World News | August featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Adaptive Biotechnologies, Strata Oncology, and more.

    Aug 24, 2020